We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Oncolytics Biotech® Inc. Announces Start of Enrollment in Randomized Phase II Ovarian Cancer Study

News   Dec 02, 2010

 
Oncolytics Biotech® Inc. Announces Start of Enrollment in Randomized Phase II Ovarian Cancer Study
 
 
Advertisement
 

RELATED ARTICLES

Study Links Sex Biases in Drug Dosage Trials to the Overmedication of Women

News

Women are more likely than men to suffer adverse effects of medications because drug dosages have historically been based on clinical trials conducted on men, suggests new study.

READ MORE

Washington University COVID-19 Vaccine Effective in Mice

News

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis

READ MORE

New Treatment Regimens Show Early Efficacy Against Drug-Resistant TB

News

New treatment regimens for multidrug-resistant tuberculosis have shown early effectiveness in 85% of patients in a cohort that included many with serious comorbidities.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE